The emotional, financial, and long-term health implications of preterm birth for babies and families can be overwhelming. With the PreTRM® Test, a clinically validated prenatal blood test, know who is at risk for preterm birth with evidence to support personalized pregnancy care.
PreTRM measures specific biomarkers, levels of certain proteins, in maternal blood during pregnancy. It is performed with a single finger prick during a mother’s routine prenatal visit at 18 to 20 weeks of pregnancy.
PreTRM reveals a mother’s individual risk of preterm birth, enabling earlier and more informed care decisions. Multiple clinical trials, including the large randomized controlled trial, PRIME, have shown consistent improvements in reducing the earliest preterm births.
A premature birth happens when a baby is born more than three weeks before the due date, or before 37 weeks of pregnancy. In the past, premature birth was hard to predict because many pregnancies show no obvious risk factors. The PreTRM Test provides early insight into preterm birth risk, helping moms and healthcare providers plan care more proactively.